Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 528-538

  Hong, Yan Li ^a   Fan, Fan Hou ^a   Zhang, Xun ^a   Ping, Yan Chen ^a   Shang, Xi Liu ^a   Jian, Xun Feng ^a   Zhi, Qiang Liu ^a   Yue, Xin Shan ^a   Guo, Bao Wang ^a   Zhan, Mei Zhou ^a   Jian, Wei Tian ^a   Xie, Di ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CREATININE; GLUTATHIONE PEROXIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN DERIVATIVE; SERUM ALBUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; ENZYME ACTIVITY; INFLAMMATION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MACROPHAGE; MALE; NEPHRECTOMY; NONHUMAN; OXIDATION; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 33846680683     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070781     Document Type: Article

References (46)

1. Collins AJ, Couser WG, Dirks JH, Kopple JD, Reiser T, Riella MC, Robinson S, Shah SV, Wilson A: World Kidney Day: An idea whose time has come. Kidney Int 69: 781-782, 2006
2. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996
3. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996
4. Kalousova M, Skrha J, Zima T: Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51: 597-604, 2002
5. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K: Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions: Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100: 2995-3004, 1997
6. Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212-2217, 2002
7. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM, Jungers P: Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 45: 39-47, 2005
8. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X: Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26: 1156-1162, 2006
9. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998
10. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noel LH, Guerin AP, London GM, Jungers P: Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers. Kidney Int 66: 1606-1612, 2004
11. Capeillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V: Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689: 91-102, 2004
12. Li HY, Hou FF, Zhang X, Liu SX, Fen JX, Liu ZQ: Advanced oxidation protein products accelerate renal dysfunction in the remnant kidney [Abstract]. In: Abstract Book, IXth Congress of Chinese Society of Nephrology, Beijing, Chinese Medical Association Press, 2005, p 47
13. Levey AS: Clinical evaluation of renal function. In: Primer on Kidney Diseases, 2nd Ed., edited by Greenberg A, San Diego, Academic Press, 1998, pp 20-26
14. Lott JA, Stephan VA, Pritchard KJ: Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. Clin Chem 29: 1946-1950, 1983
15. Raij L, Azar S, Keaue W: Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 26: 137, 1984
16. Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 15: 1773-1781, 2000
17. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 9: 224-230, 1998
18. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M: Mycophenolate mofetil reduces myofibroblast infiltration and collagen deposition in rat remnant kidney. Kidney Int 58: 51-61, 2000
19. Taal MW, Chertow GM, Rennke HG, Gurnani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM, Mackenzie HS: Mechanisms underlying renoprotection during rennin-angiotensin system blockade. Am J Physiol Renal Physiol 280: F343-F355, 2001
20. Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58: 1664-1678, 2000
21. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216, 1976
22. Flohe L, Gunzler WA: Assays of glutathione peroxidase. Methods Enzymol 105: 114-120, 1984
23. Obertop H, Malt RA: Lost mass and excretion as stimuli to parabiotic compensatory renal hypertrophy. Am J Physiol 232: F405-F408, 1977
24. Harris RH, Best CF: Circulatory retention of urinary factors as a stimulus to renal growth. Kidney Int 12: 305-312, 1977
25. Griffin KA, Picken M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4: 2023-2031, 1994
26. Kleinknecht C, Terzi F, Burtin M, Laouari D, Maniar S: Experimental models of nephron reduction: Some answers, many questions. Kidney Int Suppl 49: S51-S54, 1995
27. Griffin KA, Picken MM, Churchill M, Churchill P, Bidani AK: Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 11: 497-506, 2000
28. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 18: 1272-1280, 2003
29. Vaziri ND: Oxidative stress in uremia: Nature, mechanisms, and potential consequences. Semin Nephrol 24: 469-473, 2004
30. Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 45: 1-9, 1994
31. Klahr S: Oxygen radicals and renal diseases. Miner Electrolyte Metab 23: 140-143, 1997
32. Alderson NL, Chachich ME, Frizzell N, Canning P, Metz TO, Januszewski AS, Youssef NN, Stitt AW, Baynes JW, Thorpe SR: Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat. Diabetologia 47: 1385-1395, 2004
33. Hannken T, Schroeder R, Zahner G, Stahl RA, Wolf G: Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): Role in angiotensin II-mediated hypertrophy of proximal tubular cells. J Am Soc Nephrol 11: 1387-1397, 2000
34. Shackelford RE, Kaufmann WK, Paules RS: Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28: 1387-1404, 2000
35. Van den Branden C, Verelst R, Vamecq J, Vanden Houte K, Verbeelen D: Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidney. Nephron 76: 77-81, 1997
36. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drueke T, Santangelo F, Descamps-Latscha B: AOPPs-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 64: 82-91, 2003
37. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766, 1999
38. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000
39. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ: Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 59: 1626-1640, 2001
40. Wilson HM, Walbaum D, Rees AJ: Macrophages and the kidney. Curr Opin Nephrol Hypertens 13: 285-290, 2004
41. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152-176, 2000
42. Gong R, Rifai A, Tolbert EM, Biswas P, Centracchio JN, Dworkin LD: Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J Am Soc Nephrol 15: 2868-2881, 2004
43. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86: 453-462, 1990
44. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992
45. Porubsky S, Schmid H, Bonrouhi M, Kretzler M, Malle E, Nelson PJ, Grone HJ: Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol 164: 2175-2187, 2004
46. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538, 2002